{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:00:33Z","timestamp":1790298033364,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-026-02866-1","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:35:28Z","timestamp":1783175728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of additional PRV constraint to Direct OAR robust optimization in IMPT for targets near serial organs at risk"],"prefix":"10.1186","volume":"21","author":[{"given":"Sham","family":"Sundar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Chilukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikandan","family":"Arjunan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Guruvaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayananda Shamurailatpam","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"6Part20","key":"2866_CR1","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1118\/1.4735714","volume":"39","author":"W Liu","year":"2012","unstructured":"Liu W, Zhu X, Li X, Li Y, Zhang X, Frank S, et al. SU-E-T-624: Comparison of PTV\u2009+\u2009PRV-Based Optimization and Robust Optimization in Intensity-Modulated Proton Therapy. Med Phys. 2012;39(6Part20):3849\u201350.","journal-title":"Med Phys"},{"issue":"2","key":"2866_CR2","doi-asserted-by":"publisher","first-page":"021709","DOI":"10.1118\/1.4774363","volume":"40","author":"W Liu","year":"2013","unstructured":"Liu W, Frank SJ, Li X, Li Y, Zhu RX, Mohan R. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization. Med Phys. 2013;40(2):021709.","journal-title":"Med Phys"},{"issue":"14","key":"2866_CR3","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1088\/0031-9155\/56\/14\/011","volume":"56","author":"F Albertini","year":"2011","unstructured":"Albertini F, Hug EB, Lomax AJ. Is it necessary to plan with safety margins for actively scanned proton therapy? Phys Med Biol. 2011;56(14):4399\u2013413.","journal-title":"Phys Med Biol"},{"key":"2866_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.radonc.2022.04.007","volume":"171","author":"W Banfield","year":"2022","unstructured":"Banfield W, Ioakeim-Ioannidou M, Goldberg S, Ahmed S, Schwab JH, Cote GM, et al. Definitive high-dose, proton-based radiation for unresected mobile spine and sacral chordomas. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2022;171:139\u201345.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"5","key":"2866_CR5","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.ijrobp.2006.02.059","volume":"65","author":"L Park","year":"2006","unstructured":"Park L, Delaney TF, Liebsch NJ, Hornicek FJ, Goldberg S, Mankin H, et al. Sacral chordomas: Impact of high-dose proton\/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys. 2006;65(5):1514\u201321.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"2866_CR6","doi-asserted-by":"publisher","first-page":"101582","DOI":"10.1016\/j.adro.2024.101582","volume":"9","author":"S Chilukuri","year":"2024","unstructured":"Chilukuri S, Burela N, Sundar S, Kamath R, Nangia S, Arjunan M, et al. Impact of Dosimetric Compromises on Early Outcomes of Chordomas and Chondrosarcomas Treated With Image-guided Pencil Beam Scanning Proton Beam Therapy. Adv Radiat Oncol. 2024;9(10):101582.","journal-title":"Adv Radiat Oncol"},{"issue":"4","key":"2866_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3171\/2015.7.SPINE15201","volume":"24","author":"ZL Gokaslan","year":"2016","unstructured":"Gokaslan ZL, Zadnik PL, Sciubba DM, Germscheid N, Goodwin CR, Wolinsky JP, et al. Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database. J Neurosurg Spine. 2016;24(4):644\u201351.","journal-title":"J Neurosurg Spine"},{"issue":"3","key":"2866_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3171\/2014.5.SPINE121045","volume":"21","author":"CA Molina","year":"2014","unstructured":"Molina CA, Ames CP, Chou D, Rhines LD, Hsieh PC, Zadnik PL, et al. Outcomes following attempted en bloc resection of cervical chordomas in the C-1 and C-2 region versus the subaxial region: a multiinstitutional experience. J Neurosurg Spine. 2014;21(3):348\u201356.","journal-title":"J Neurosurg Spine"},{"issue":"2","key":"2866_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00586-009-1137-z","volume":"19","author":"S Boriani","year":"2010","unstructured":"Boriani S, Bandiera S, Donthineni R, Amendola L, Cappuccio M, De Iure F, et al. Morbidity of en bloc resections in the spine. Eur Spine J. 2010;19(2):231\u201341.","journal-title":"Eur Spine J"},{"issue":"6\u20137","key":"2866_CR10","first-page":"658","volume":"24","author":"A Rousselle","year":"2020","unstructured":"Rousselle A, Amelot A, Thariat J, Jacob J, Mercy G, De Marzi L, et al. Metallic implants and CT artefacts in the CTV area: Where are we in 2020? Cancer Radiother J Soc Francaise Radiother Oncol. 2020;24(6\u20137):658\u201366.","journal-title":"Cancer Radiother J Soc Francaise Radiother Oncol"},{"issue":"7","key":"2866_CR11","doi-asserted-by":"publisher","first-page":"071727","DOI":"10.1118\/1.4810942","volume":"40","author":"JM Verburg","year":"2013","unstructured":"Verburg JM, Seco J. Dosimetric accuracy of proton therapy for chordoma patients with titanium implants. Med Phys. 2013;40(7):071727.","journal-title":"Med Phys"},{"issue":"1","key":"2866_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1055\/s-0035-1554907","volume":"77","author":"W Choy","year":"2016","unstructured":"Choy W, Terterov S, Ung N, Kaprealian T, Trang A, DeSalles A, et al. Adjuvant Stereotactic Radiosurgery and Radiation Therapy for the Treatment of Intracranial Chordomas. J Neurol Surg Part B Skull Base. 2016;77(1):38\u201346.","journal-title":"J Neurol Surg Part B Skull Base"},{"issue":"1","key":"2866_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.radonc.2016.05.011","volume":"120","author":"DC Weber","year":"2016","unstructured":"Weber DC, Malyapa R, Albertini F, Bolsi A, Kliebsch U, Walser M, et al. Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2016;120(1):169\u201374.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"4","key":"2866_CR14","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.ijrobp.2024.04.007","volume":"120","author":"AM Chhabra","year":"2024","unstructured":"Chhabra AM, Snider JW, Kole AJ, Stock M, Holtzman AL, Press R, et al. Proton Therapy for Spinal Tumors: A Consensus Statement From the Particle Therapy Cooperative Group. Int J Radiat Oncol Biol Phys. 2024;120(4):1135\u201348.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1062","key":"2866_CR15","doi-asserted-by":"publisher","first-page":"20150988","DOI":"10.1259\/bjr.20150988","volume":"89","author":"K Miki","year":"2016","unstructured":"Miki K, Mori S, Hasegawa A, Naganawa K, Koto M. Single-energy metal artefact reduction with CT for carbon-ion radiation therapy treatment planning. Br J Radiol. 2016;89(1062):20150988.","journal-title":"Br J Radiol"},{"issue":"4","key":"2866_CR16","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/jmri.25708","volume":"46","author":"PM Jungmann","year":"2017","unstructured":"Jungmann PM, Agten CA, Pfirrmann CW, Sutter R. Advances in MRI around metal. J Magn Reson Imaging JMRI. 2017;46(4):972\u201391.","journal-title":"J Magn Reson Imaging JMRI"},{"issue":"1","key":"2866_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ijrobp.2005.08.038","volume":"64","author":"SL Breen","year":"2006","unstructured":"Breen SL, Craig T, Bayley A, O\u2019Sullivan B, Kim J, Jaffray D. Spinal cord planning risk volumes for intensity-modulated radiation therapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;64(1):321\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2866_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3171\/2016.8.SPINE16121","volume":"26","author":"KJ Redmond","year":"2017","unstructured":"Redmond KJ, Lo SS, Soltys SG, Yamada Y, Barani IJ, Brown PD, et al. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. J Neurosurg Spine. 2017;26(3):299\u2013306.","journal-title":"J Neurosurg Spine"},{"issue":"6","key":"2866_CR19","doi-asserted-by":"publisher","first-page":"101047","DOI":"10.1016\/j.adro.2022.101047","volume":"7","author":"JJ Lucido","year":"2022","unstructured":"Lucido JJ, Mullikin TC, Abraha F, Harmsen WS, Vaishnav BD, Brinkmann DH, et al. Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy. Adv Radiat Oncol. 2022;7(6):101047.","journal-title":"Adv Radiat Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-026-02866-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02866-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02866-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:18:02Z","timestamp":1790295482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-026-02866-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2866"],"URL":"https:\/\/doi.org\/10.1186\/s13014-026-02866-1","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was a dosimetric treatment-planning analysis performed using previously generated radiotherapy planning datasets and did not involve prospective recruitment of human participants, patient interaction, or identifiable patient information. According to the Indian Council of Medical Research (ICMR) National Ethical Guidelines for Biomedical and Health Research Involving Human Participants (2017), research involving analysis of anonymous or non-identified datasets is categorized as less than minimal risk. Based on the use of anonymized data and the non-interventional nature of this technical dosimetric study, formal ethics committee approval and individual informed consent were waived. The study was conducted in accordance with applicable institutional research policies and the principles of the Declaration of Helsinki where applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not involve direct participation of human subjects.","order":2,"name":"Ethics","label":"Consent for participation","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"128"}}